Ligand Binding Mode Prediction by Docking: Mdm2/Mdmx Inhibitors as a Case Study-Reference-Cited by-同舟云学术

Ligand Binding Mode Prediction by Docking: Mdm2/Mdmx Inhibitors as a Case Study

Published:2014-01-21 Issue:2 Volume:54 Page:648-659
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Bharatham Nagakumar¹,Bharatham Kavitha¹,Shelat Anang A.¹,Bashford Donald¹

Affiliation:

1. Department of Structural Biology and ‡Department of Chemical Biology and Therapeutics, Saint Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States

Funder

National Institutes of Health

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci4004656

Reference79 articles.

1. Live or let die: the cell's response to p53

2. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome

3. Control of apoptosis by p53

4. p53, guardian of the genome

5. The p53-mdm-2 autoregulatory feedback loop.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor studies on celastrol and its derivatives as RORα agonists and RORγ inhibitors based on Alphafold reverse docking strategy;Medicinal Chemistry Research;2024-04-12

2. Structure–Activity Relationship Studies of Chalcones and Diarylpentanoids with Antitumor Activity: Potency and Selectivity Optimization;Pharmaceuticals;2023-09-25

3. Computational-based drug design of novel small molecules targeting p53-MDMX interaction;Journal of Biomolecular Structure and Dynamics;2023-08-14

4. Development of New Molecules Through Molecular Docking;Industrial Microbiology and Biotechnology;2023

5. Comprehensive molecular docking and dynamic simulations for drug repurposing of clinical drugs against multiple cancer kinase targets;Journal of Biomolecular Structure and Dynamics;2022-09-22